Patient access scheme (PAS)

Patient access schemes are special ways pharmaceutical companies can propose to enable patients to gain access to high costs medicines. PAS is the name for Ü managed entry agreements in the United Kingdom. They are proposed by a pharmaceutical company and agreed between the Department of Health and the pharmaceutical company; as other managed entry agreements they can take different forms (e.g. financial or performance based agreement). Cf. managed entry agreements